Identification of synaptic vesicle, pre‐ and postsynaptic proteins in human cerebrospinal fluid using liquid‐phase isoelectric focusing

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Electrophoresis

• Publication date

  1999-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1522-2683(19990301)20:3<431::AID-ELPS431>3.0.CO;2-2PMID 10217148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new procedure for detecting brain-specific proteins in cerebrospinal fluid

  2005cited by this paper
• Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele

  2005cited by this paper
• Neurochemical Dissection of Synaptic Pathology in Alzheimer's Disease

  1998cited by this paper
• Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients

  1998cited by this paper
• Dendritic Translocation of RC3/Neurogranin mRNA in Normal Aging, Alzheimer Disease and Fronto‐Temporal Dementia

  1997cited by this paper
• Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.

  1997cited by this paper
• GAP-43: an intrinsic determinant of neuronal development and plasticity.

  1997cited by this paper
• Rab3D localizes to secretory granules in rat pancreatic acinar cells.

  1996cited by this paper
• Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease?

  1996cited by this paper
• Synaptic degeneration in thalamus in schizophrenia.

  1996cited by this paper
• Purification of a 3β-Hydroxy-Δ5-C27-steroid Dehydrogenase from Pig Liver Microsomes Active in Major and Alternative Pathways of Bile Acid Biosynthesis*

  1996cited by this paper
• Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia.

  1996cited by this paper
• Aberrant GAP-43 gene expression in Alzheimer's disease.

  1995cited by this paper
• Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease.

  1995cited by this paper
• Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia.

  1995cited by this paper
• The synaptic vesicle cycle: a cascade of protein–protein interactions

  1995cited by this paper
• Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography.

  1995cited by this paper
• Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method.

  1995cited by this paper
• Localization of RC3 (neurogranin) in rat brain subcellular fractions.

  1994cited by this paper
• Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with the dementia of Alzheimer type and nondemented controls.

  1994cited by this paper
• Specificity and regulation of a synaptic vesicle docking complex.

  1994cited by this paper
• Identification and characterization of capsaicin-hydrolyzing enzymes purified from rat liver microsomes.

  1994cited by this paper
• Micropurification of Two Human Cerebrospinal Fluid Proteins by High Performance Electrophoresis Chromatography

  1993cited by this paper
• Neurobiological investigations in cingulate cortex of schizophrenic brain.

  1993cited by this paper
• Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25

  1993cited by this paper
• SNAP receptors implicated in vesicle targeting and fusion

  1993cited by this paper
• Botulinum neurotoxins serotypes A and E cleave SNAP‐25 at distinct COOH‐terminal peptide bonds

  1993cited by this paper
• Use of Rotofor in two‐dimensional electrophoretic analysis: Identification of a 100 kDa monoclonal IgG heavy chain in myeloma serum

  1993cited by this paper
• Isolation of a novel cytotoxic lymphokine (factor 2) from a human B-cell line (Karpas 160b) by preparative isoelectric focusing in the rotofor cell and chromatofocusing.

  1993cited by this paper
• Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia.

  1993cited by this paper
• Neurogranin, a B‐50/GAP‐43‐immunoreactive C‐kinase substrate (BICKS), is ADP‐ribosylated

  1993cited by this paper
• Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

  1993cited by this paper
• Synaptotagmin: a membrane constituent of neuropeptide-containing large dense-core vesicles

  1993cited by this paper
• Characterization of an eosinophilic leukemia cell differentiation factor (ELDF) produced by a human T cell leukemia cell line, HIL-3.

  1993cited by this paper
• Membrane fusion machinery: insights from synaptic proteins.

  1993cited by this paper
• Synaptic Vesicle Traffic: Rush Hour in the Nerve Terminal

  1993cited by this paper
• Protein Analysis in Cerebrospinal Fluid

  1993cited by this paper
• Synaptotagmin: a calcium sensor on the synaptic vesicle surface.

  1992cited by this paper
• Purification of serum amyloid A and its isoforms from human plasma by hydrophobic interaction chromatography and preparative isoelectric focusing

  1992cited by this paper
• Abnormal reinnervation as a basis for schizophrenia: a hypothesis.

  1992cited by this paper
• Immunocytochemical detection of the growth-associated protein B-50 by newly characterized monoclonal antibodies in human brain and muscle.

  1992cited by this paper
• Increased Phosphorylation of a 17‐kDa Protein Kinase C Substrate (P17) in Long‐Term Potentiation

  1992cited by this paper
• Purification and patch clamp analysis of a 40-pS channel from rat liver mitochondria.

  1992cited by this paper
• The M20 IL-1 inhibitor. I. Purification by preparative isoelectric focusing in free solution.

  1992cited by this paper
• Proteins of synaptic vesicles involved in exocytosis and membrane recycling.

  1991cited by this paper
• Association of Rab3A with synaptic vesicles at late stages of the secretory pathway

  1991cited by this paper
• Purification and characterization of a brain-specific protein kinase C substrate, neurogranin (p17). Identification of a consensus amino acid sequence between neurogranin and neuromodulin (GAP43) that corresponds to the protein kinase C phosphorylation site and the calmodulin-binding domain.

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• rab3 is a small GTP-binding protein exclusively localized to synaptic vesicles.

  1990cited by this paper
• Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C

  1990cited by this paper
• Localization of the growth-associated phosphoprotein GAP-43 (B-50, F1) in the human cerebral cortex

  1989cited by this paper
• Primary structure and transcriptional regulation of GAP-43, a protein associated with nerve growth.

  1987cited by this paper
• Cloning and sequence analysis of cDNA encoding p38, a major synaptic vesicle protein

  1987cited by this paper
• The cDNA and derived amino acid sequences for rat and human synaptophysin.

  1987cited by this paper
• Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots.

  1983cited by this paper
• Changes in axonally transported proteins during axon regeneration in toad retinal ganglion cells

  1981cited by this paper
• Separation of cerebrospinal fluid specific proteins -- a methodological study. Part I.

  1980cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Associations between fluid biomarkers and PET imaging ([11C]UCB‐J) of synaptic pathology in Alzheimer's disease

  2025cites this paper
• Synaptic markers are associated with cognitive decline after accounting for amyloid burden among an at-risk Alzheimer’s disease cohort

  2025cites this paper
• Synaptosomal‐Associated Protein 25 kDA (SNAP‐25) Levels in Cerebrospinal Fluid: Implications for Alzheimer's Disease Diagnosis and Monitoring

  2025cites this paper
• Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases

  2024cites this paper
• Biomarkers in Alzheimer’s Disease: Are Olfactory Neuronal Precursors Useful for Antemortem Biomarker Research?

  2024cites this paper
• Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease

  2022cites this paper
• Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders

  2022cites this paper
• Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids

  2021cites this paper
• Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment

  2021cites this paper
• Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease

  2020cites this paper
• Blood and cerebrospinal fluid biomarkers for Alzheimer’s disease

  2020cites this paper
• The role of synaptic biomarkers in the spectrum of neurodegenerative diseases

  2020cites this paper
• Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2020cites this paper
• The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease

  2020cites this paper
• Fluid Biomarkers for Synaptic Dysfunction and Loss

  2020cites this paper
• Proteomic studies of cerebrospinal fluid biomarkers for Alzheimer's disease: an update

  2019cites this paper
• Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings.

  2019cites this paper
• The Past and the Future of Alzheimer’s Disease Fluid Biomarkers1

  2018cites this paper
• Implication of preclinical biomarkers in identification of mild cognitive impairment (MCI) and Alzheimer’s disease: Promises and future challenges

  2018influential citation
• Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase

  2018cites this paper
• Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease

  2018cites this paper
• Biomarkers for Alzheimer's disease: current status and prospects for the future

  2018cites this paper
• Levels of ADAM10 are reduced in Alzheimer’s disease CSF

  2018cites this paper
• Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

  2018cites this paper
• a Circulating cell free mitochondrial DNA copy number variation in neurodegenerative disease

  2018cites this paper
• Dynamics of proteinopathies in Alzheimer’s disease as measured by PET and CSF biomarkers

  2018cites this paper
• Current development and challenges in biomarkers for early identification of mild cognitive impairment and alzheimer’s disease

  2018cites this paper
• Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia

  2018cites this paper
• Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)

  2017cites this paper
• Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons

  2017cites this paper
• Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease

  2017cites this paper
• Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer’s disease: an update

  2017cites this paper
• CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease

  2016cites this paper
• Fluid Biomarkers and Diagnostics

  2016cites this paper
• Assessment of ZnT 3 and PSD 95 protein levels in Lewy body dementias and Alzheimer ' s disease : association with cognitive impairment

  2016cites this paper
• Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.

  2015cites this paper
• Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

  2015cites this paper
• Neurogranin Levels in Cerebrospinal Fluid: A New Addition to the Alzheimer Disease Diagnostic Toolbox.

  2015cites this paper
• Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

  2015cites this paper
• Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

  2015cites this paper
• Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?*

  2015cites this paper
• C‐terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

  2015cites this paper
• Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments

  2015cites this paper
• Alzheimer’s Disease and Other Neurodegenerative Disorders

  2015cites this paper
• Featured Article Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

  2015cites this paper
• Intracellular and Extracellular Roles for Tau in Neurodegenerative Disease

  2014cites this paper
• Cerebrospinal fluid analysis in Alzheimer’s disease: technical issues and future developments

  2014cites this paper
• SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease

  2014cites this paper
• An investigation into the relationships between synaptic biochemistry, clinical symptoms and pathology in the Lewy body dementias and Alzheimer's disease

  2014cites this paper
• Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment.

  2014cites this paper
• Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia

  2014cites this paper
• CSF in Alzheimer's disease.

  2014cites this paper
• OPINION Cerebrospinal fluid biomarkers for pathological processes in Alzheimer’s disease

  2013cites this paper
• Molecular biomarkers of neurodegeneration

  2013cites this paper
• Applied proteomics : using the peripheral proteome to identify a surrogate marker of schizophrenia

  2012influential citation
• Fluid biomarkers in Alzheimer disease.

  2012cites this paper
• Proteomic profile of edible bird's nest proteins.

  2012cites this paper
• Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?

  2012cites this paper
• Biomarker-based dissection of neurodegenerative diseases.

  2011cites this paper
• Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future

  2011influential citation
• Biomarkers in Alzheimer's disease drug development

  2010cites this paper
• An overview of biomarkers in Alzheimer’s disease

  2010cites this paper
• Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain

  2010cites this paper
• Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

  2010cites this paper
• Effective prevention against rabies by intracerebral immunization in mice.

  2009cites this paper
• CSF Biomarkers

  2009cites this paper
• Hunting down fungal secretomes using liquid‐phase IEF prior to high resolution 2‐DE

  2009cites this paper
• Evaluation of a solution isoelectric focusing protocol as an alternative to ion exchange chromatography for charge-based proteome prefractionation.

  2009cites this paper
• Clinical proteomics in neurodegenerative disorders

  2008cites this paper
• Fractionation of complex protein mixtures by liquid-phase isoelectric focusing.

  2008cites this paper
• Proteomics of Alzheimer’s disease: understanding mechanisms and seeking biomarkers

  2007cites this paper
• Comparison of antibody titers in rabbits following immunization with inactivated influenza virus via subarachnoidal or subcutaneous route.

  2007cites this paper
• Biological Markers in Alzheimer's Disease

  2007cites this paper
• Efficacy of Intracerebral Immunization against Pseudorabies Virus in Mice

  2006cites this paper
• Glomerular clusterin is associated with PKC-α/β regulation and good outcome of membranous glomerulonephritis in humans

  2006cites this paper
• Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans.

  2006cites this paper
• The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases

  2005cites this paper
• A subcellular prefractionation protocol for minute amounts of mammalian cell cultures and tissue

  2005cites this paper
• Proteomics analysis of human cerebrospinal fluid.

  2005cites this paper
• Protein Analysis in Human Cerebrospinal Fluid: Physiological Aspects, Current Progress and Future Challenges

  2005cites this paper
• Cerebrospinal fluid protein biomarkers for Alzheimer’s disease

  2004cites this paper
• Cerebrospinal fluid protein biomarkers for Alzheimer’s disease

  2004cites this paper
• Electrophoretic Prefractionation for Comprehensive Analysis of Proteomes

  2004cites this paper
• Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease.

  2003cites this paper
• Proteomics analysis of phosphotyrosyl-proteins in human lumbar cerebrospinal fluid.

  2003cites this paper
• Elevated cerebrospinal fluid SNAP-25 in schizophrenia.

  2003cites this paper
• Comparison of preparative and analytical two-dimensional electrophoresis for isolation and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometric analysis of transthyretin in cerebrospinal fluid.

  2002cites this paper
• Aktuelle klinisch-neurochemische Diagnostik der Alzheimer-Krankheit/Current Clinical Neurochemical Diagnosis of Alzheimer’s Disease

  2002cites this paper
• Both total and phosphorylated tau are increased in Alzheimer's disease

  2001cites this paper
• Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two‐dimensional electophoresis approach prior to mass spectrometry

  2001cites this paper
• Proteomics in neuropsychiatric disorders.

  2001cites this paper
• New separation tools for comprehensive studies of protein expression by mass spectrometry.

  2000cites this paper
• Proteomics in molecular medicine: Applications in central nervous systems disorders

  2000cites this paper
• Analysis of intact proteins from cerebrospinal fluid by matrix-assisted laser desorption/ionization mass spectrometry after two-dimensional liquid-phase electrophoresis.

  1999cites this paper
• Peptide mapping of proteins in cerebrospinal fluid utilizing a rapid preparative two-dimensional electrophoretic procedure and matrix-assisted laser desorption/ionization mass spectrometry.

  1999cites this paper
• Identification of proteins in a human pleural exudate using two‐dimensional preparative liquid‐phase electrophoresis and matrix‐assisted laser desorption/ionization mass spectrometry

  1999cites this paper